MarketsandMarkets Next-Gen Bioprocessing Global Virtual Conference (Time zone: CET)

3rd - 4th November 2022

EVENT OVERVIEW

Devising Effective Manufacturing & Quality Control Methods of Cell Therapies

Over the last 50 years, the bioprocessing industry has witnessed tremendous change, overcoming many challenges to increase efficiency and productivity throughout the development and manufacturing process. These efforts have been particularly focused to elicit major advancements for cell lines, culture media, and downstream processes used to produce therapeutics.

MarketsandMarkets is extremely delighted to announce its “ MarketsandMarkets Next-Gen Bioprocessing Virtual Conference” scheduled to be held on 6th- 7th October 2022. The conference is designed for having interactive discussions in cell culture, scale-up, continuous biomanufacturing, recovery, purification, process and product characterization, formulation, case studies in analytics and stability. The conference also includes interactive breakout sessions, solutions and services supporting the rapidly growing bioprocessing industry. The event will witness the participation of decision makers from the pharmaceutical industry who are shaping the future of the bioprocessing industry.

WHAT TO EXPECT

CELL CULTURE & BIOPRODUCTION

  • Protein synthesis and cell line development
  • Bioproduction 4.0
  • Bioprocess development strategies
  • Process monitoring and control
  • Bioproduction innovations

DOWNSTREAM PROCESSING & CONTINUOUS BIOMANUFACTURING

  • Upstream and downstream process optimization
  • Enhancing protein purification
  • Biomanufacturing 2030: The latest manufacturing shift
  • Pharma 4.0 trends and new drug delivery strategies
  • Commercial manufacturing case studies

CELL AND GENE THERAPY ANALYTICS & MANUFACTURING

  • Cell & Gene therapy analytics and characterization
  • Emerging analytical methods & Quality Control
  • AAV scale-up and manufacturing
  • Cell & Gene therapy process development
  • Navigating cell & gene therapy CMC and comparability

CEO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Investigators, Heads, Managers, Principal scientists, Scientists, Professors, Lecturers, Group Heads & Researchers

From Pharmaceuticals/Therapeutics/Cell-Gene therapy-based companies.
Academics: Universities/ Research Labs/Research Institutes  

• Working on:

  • Bioprocess development
  • Process development
  • GMP/Manufacturing
  • Cellular Therapy
  • Gene Therapy
  • Quality Control
  • Cell Engineering
  • Scale up Bioprocessing
  • Scale down bioprocessing
  • Fermentation
  • Cell Therapy
  • Cell culture operations
  • mRNA type therapeutics
  • ATMP (Advanced therapy medicinal products)
  • CAR T-cell therapy
  • Monoclonal antibodies (mAbs)
  • Viral vectors

 

  • Participate in discussions with experts on how technology implementation can be improved
  • Attracting and retaining world-class pharma and biotech talent
  • Improve the efficiency of bio-manufacturing by engaging in environmentally sustainable methods
  • Resolve common contamination and R&D challenges
  • Discover the latest technology implementations in the industry
  • Discover best-in-class solutions during the workshop sessions
  • Interactive panel discussions

CONFERENCE AGENDA

Welcome note from MarketsandMarkets

 14:00 - 14:35

Opening Remarks from the Chairperson

Rohan Kamat

Rohan Kamat, Head R&D division, Immuneel Therapeutics

 14:05 - 14:15

Keynote Presentation – Making CAR-T cell therapies affordable to the Indian sub-continent

Rohan Kamat

Rohan Kamat, Head R&D division, Immuneel Therapeutics

 14:15 - 14:45

UPSTREAM & DOWNSTREAM PROCESSING

CAR T-cell immunotherapy of solid tumors: Parallel learning from the clinic and lab

John Maher

John Maher, Chief Scientific Officer, Leucid Bio

 14:45 - 15:15

Role of Cellular Post Translational Modifications in Regulating Growth and Productivity of Recombinant Chinese Hamster Ovary Cells

Paula Meleady

Paula Meleady, Associate Director, National Institute for Cellular Biotechnology

 15:15 - 15:45

Antibody-targeted lipid-nanoparticle mediated inhibition of the GPCR RXFP1 signaling pathway as a therapeutic approach for ovarian cancer

Itai Benhar

Itai Benhar, Professor, Tel Aviv University

 15:45 - 16:15

Microfluidics in the delivery of biologics

Dimitrios A. Lamprou

Dimitrios A. Lamprou, Professor (chair) of Biofabrication and Advanced Manufacturing, Queen’s University Belfast

 16:15 - 16:45

Closing Remarks from the Chairman

 16:45 - 16:45

Welcome note from MarketsandMarkets

 14:00 - 14:10

Opening Remarks from the Chairman

Rohan Kamat

Rohan Kamat, Head R&D division, Immuneel Therapeutics

 14:10 - 14:15

Keynote Presentation- Apheresis Collections in Cell & Gene Therapy

Joseph M. Roig

Joseph M. Roig, Associate Technical Director, Apheresis | Global MSAT Cell Therapy Development and Operations, Bristol Myers Squibb

 14:15 - 14:45

ADVANCES IN CELL & GENE THERAPY

A convenient self-removing affinity tag to streamline biopharmaceutical discovery through manufacturing

Dr. Izabela Gierach

Dr. Izabela Gierach, CEO and Co-Founder, Protein Capture Science

 14:45 - 15:15

Analytical Development for Extracellular Vesicles

Andrew Splevins

Andrew Splevins, Senior Development Director, CMC, Evox Therapeutics Ltd

 15:15 - 15:45

Microproteins are a new class of potential host cell impurity in monoclonal antibody (mAb) drug products

Ioanna Tzani

Ioanna Tzani, Postdoctoral Researcher, The National Institute for Bioprocessing Research and Training

 15:45 - 16:15

VACCINE & mRNA THERAPEUTICS

Scalable manufacturing of ex vivo gene therapy product using human mesenchymal stromal cells (hMSCs)

Pedro Silva Couto

Pedro Silva Couto, Post-Doctoral Research Fellow, University College London

 16:15 - 16:45

Closing Remarks from the Chairperson

 16:45 - 16:45

End of Conference

 16:45 - 16:45

CONFERENCE SPEAKERS

ADVISORS

Dimitrios A. Lamprou

Dimitrios A. Lamprou

Professor (chair) of Biofabrication and Advanced Manufacturing, Queen’s University Belfast

SPEAKERS

Dimitrios A. Lamprou

Dimitrios A. Lamprou

Professor (chair) of Biofabrication and Advanced Manufacturing, Queen’s University Belfast

John Maher

John Maher

Chief Scientific Officer, Leucid Bio

Paula Meleady

Paula Meleady

Associate Director, National Institute for Cellular Biotechnology

Ioanna Tzani

Ioanna Tzani

Postdoctoral Researcher, The National Institute for Bioprocessing Research and Training

Pedro Silva Couto

Pedro Silva Couto

Post-Doctoral Research Fellow, University College London

Andrew Splevins

Andrew Splevins

Senior Development Director, CMC, Evox Therapeutics Ltd

Joseph M. Roig

Joseph M. Roig

Associate Technical Director, Apheresis | Global MSAT Cell Therapy Development and Operations, Bristol Myers Squibb

Itai Benhar

Itai Benhar

Professor, Tel Aviv University

Rohan Kamat

Rohan Kamat

Head R&D division, Immuneel Therapeutics

Dr. Izabela Gierach

Dr. Izabela Gierach

CEO and Co-Founder, Protein Capture Science

24/7 Customer Support

Asia Office

Phone : +91 20 48598285
[email protected]

USA Office

Phone : +1-888600-6441
[email protected]